EGFR and lung adenocarcinoma: However, a recent study of 1,478 U.S. patients with lung adenocarcinomas found no association of ERBB2 mutation with sex and race, but confirmed that mutations of the kinase domain of ERBB2 are mutually exclusive with EGFR, KRAS, and ALK mutations (Arcila et al., 2012).